Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Emergence of drug resistance in HIV-1 subtype C infected children failing the South African national antiretroviral roll-out program.

Wallis CL, Erasmus L, Varughese S, Ndiweni D, Stevens WS.

Pediatr Infect Dis J. 2009 Dec;28(12):1123-5. doi: 10.1097/INF.0b013e3181af5a00.

PMID:
19935274
2.

Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.

Saez-Llorens X, Violari A, Ndiweni D, Yogev R, Cashat M, Wiznia A, Chittick G, Harris J, Hinkle J, Blum MR, Adda N, Rousseau F; FTC-203 Study Team..

Pediatrics. 2008 Apr;121(4):e827-35. doi: 10.1542/peds.2006-3078.

PMID:
18332076
3.

Altered PBP 2A and its role in the development of penicillin, cefotaxime, and ceftriaxone resistance in a clinical isolate of Streptococcus pneumoniae.

Smith AM, Feldman C, Massidda O, McCarthy K, Ndiweni D, Klugman KP.

Antimicrob Agents Chemother. 2005 May;49(5):2002-7.

Supplemental Content

Loading ...
Support Center